Product Information

NAPROXEN DR 500 MG TABLET is a generic product labeled by TruPharma LLC, priced at $1.8643 per EA under NDC 52817038110. Its NADAC has been published 142 times since Dec 6, 2023.

FDA first approved this application on May 31, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Naproxen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for NAPROXEN DR 500 MG TABLET has been published 142 times since Dec 6, 2023, and over the history we have for it it has declined 43.9%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 97% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.